Algernon Pharmaceuticals

Algernon Pharmaceuticals is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) and chronic cough, and COVID-19.
Company Feed

Subscribe and receive the investor Info
Thank you!
Download Investor KitOops! Something went wrong while submitting the form.




